1. Cellphire Completes Enrollment of Phase 1 Clinical Trial of Thrombosomes®

    ROCKVILLE, Md. (July 18, 2019) – Cellphire, Inc., the global leader in long-term cell stabilization and storage of platelets and other cells, announced today that the company completed enrollment of its Phase 1 clinical trial to evaluate Thrombosomes® in bleeding, thrombocytopenic patients. Thrombosomes is a freeze-dried hemostatic agent derived from human platelets.“The success in completing […]